WHO ICTRP trial
Total hip arthroplasty patients with distinct postoperative fibrinolytic…
ChiCTR2200056865 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2200056865 |
|---|---|
| Public title | Total hip arthroplasty patients with distinct postoperative fibrinolytic phenotypes require different antifibrinolytic strategies: a case records based retrospective study |
| Scientific title | Total hip arthroplasty patients with distinct postoperative fibrinolytic phenotypes require different antifibrinolytic strategies: a case records based retrospective study |
| Primary sponsor | The First Affiliated Hospital of Chongqing Medical University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Observational study |
| Phase | Retrospective study |
| Countries | China |
| Interventions | Group A:No post-operative TXA;Group B:1g TXA was received at 3h, 12h, 24h, 48h and 72h after operation |
| Registration date | Feb 21, 2022 |
| Target size | Group A:106;Group B:132 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: